Company research / BFNH
Bioforce Nanosciences Holdings, Inc. (BFNH)
- Sector Manufacturing
- Fiscal year ends Dec 31
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.
Annual financials
| Period ended | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a | $17.8K | $16.3K | $4.5K |
| Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | $13.4K | $11.6K | $3.2K |
| Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | $4.4K | $4.7K | $1.3K |
| Operating Income | n/a | n/a | n/a | n/a | n/a | n/a | -$46.5K | -$66.7K | -$31.3K |
| Net Income | -$1.29M | -$490.4K | -$472.0K | -$485.5K | -$502.0K | -$158.41M | -$46.5K | -$67.7K | -$31.3K |
| EPS (Diluted) | -$0.04 | -$0.02 | -$0.02 | -$0.02 | n/a | n/a | n/a | n/a | n/a |
| Total Assets | $786 | $862 | $638 | $734 | $11.1K | $39.9K | $58.9K | $35.1K | $20.9K |
| Total Liabilities | $619.3K | $2.30M | $1.82M | $1.35M | $873.0K | $399.8K | $11.6K | $5.3K | $12.7K |
| Shareholders' Equity | -$618.5K | -$2.30M | -$1.82M | -$1.35M | -$861.9K | -$359.9K | $47.3K | $29.8K | $8.2K |
| Cash & Equivalents | $786 | $862 | $638 | $734 | $11.1K | $39.9K | $52.9K | $29.4K | $14.3K |
| Operating Cash Flow | -$65.2K | -$61.2K | -$46.7K | -$68.4K | -$77.8K | -$80.2K | -$24.4K | -$62.5K | -$25.9K |
| Shares Outstanding | 33.52M | 29.27M | 29.27M | 29.27M | 29.27M | 29.27M | 15.27M | 15.26M | 76.30M |
| Weighted Average Diluted Shares | 33.21M | 29.27M | 29.27M | 29.27M | n/a | n/a | n/a | n/a | n/a |
| EPS (Basic) | -$0.04 | -$0.02 | -$0.02 | -$0.02 | n/a | n/a | n/a | n/a | n/a |